Search Results - hui+yao+lan

1 Results

Sort By:

Genetic Engineering a TGF-beta Tolerant human NK Cells for treatment of cancer.

[Licensing negotiation in progress][Invitation for Expression of Interest- Deadline: 6 December 2018]We are inviting expressions of interest (EoI) for commercializing “Genetic Engineering a TGF-beta Tolerant human NK Cells for treatment of cancer” technology. The innovation is developed by Professor LAN Hui Yao, Professor of Department...

Inventor(s): Hui Yao LAN

Keywords(s):

Category(s): Therapeutics